Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride + calcium chloride + magnesium chloride + sodium acetate anhydrous + potassium chloride
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
TPN Electrolytes is a fixed-dose **intravenous multi-electrolyte additive** containing sodium chloride, calcium chloride, magnesium chloride, sodium acetate anhydrous, and potassium chloride. Developed by Hospira and marketed within Pfizer's portfolio, it is used as a supplement to parenteral nutrition solutions, particularly concentrated dextrose and amino acid admixtures administered by central venous infusion, to help maintain or prevent disturbances in electrolyte and acid-base homeostasis in adults receiving total parenteral nutrition. Its pharmacologic effect is replacement and maintenance of essential physiologic electrolytes: sodium, potassium, calcium, and magnesium directly replenish extracellular and intracellular ionic requirements, while acetate serves as a bicarbonate precursor that supports metabolic buffering. The product is a concentrated sterile solution intended for intravenous use only after dilution and thorough mixing in nutritional solutions.
- Brand names
- TPN Electrolytes
- Other names
- multiple electrolyte additivesodium chloride + calcium chloride + magnesium chloride + sodium acetate anhydrous + potassium chloride
Beyond the preview
Go deeper on sodium chloride + calcium chloride + magnesium chloride + sodium acetate anhydrous + potassium chloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride + calcium chloride + magnesium chloride + sodium acetate anhydrous + potassium chloride.